Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 23.12%10.11M | ---- | -12.45%8.21M | ---- | 71.18%9.38M | ---- | -41.46%5.48M | ---- | -21.39%9.36M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 2.77%-1.62M | ---- | -279.22%-1.66M | ---- | -3,881.82%-438K | ---- | 96.92%-11K | ---- | 57.50%-357K |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.29%109K |
| Dividend (income)- adjustment | ---- | -5.56%-19K | ---- | -20.00%-18K | ---- | -50.00%-15K | ---- | ---10K | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -106.84%-18K | ---- | 34.18%263K | ---- | --196K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 164.82%813K | ---- | -41.30%307K | ---- | -34.63%523K | ---- | -38.37%800K | ---- | 56.57%1.3M |
| -Impairmen of inventory (reversal) | ---- | 184.78%823K | ---- | -51.99%289K | ---- | -15.57%602K | ---- | -46.23%713K | ---- | 55.45%1.33M |
| -Impairment of trade receivables (reversal) | ---- | -155.56%-10K | ---- | 122.78%18K | ---- | -190.80%-79K | ---- | 410.71%87K | ---- | -16.67%-28K |
| Revaluation surplus: | ---- | 109.57%1.45M | ---- | 553.95%690K | ---- | -850.00%-152K | ---- | -206.67%-16K | ---- | --15K |
| -Other fair value changes | ---- | 109.57%1.45M | ---- | 553.95%690K | ---- | -850.00%-152K | ---- | -206.67%-16K | ---- | --15K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---50K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---50K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -21.25%3.64M | ---- | 5.73%4.62M | ---- | 2.68%4.37M | ---- | 23.60%4.25M | ---- | 21.94%3.44M |
| Financial expense | ---- | 96.23%208K | ---- | -30.26%106K | ---- | 8.57%152K | ---- | --140K | ---- | ---- |
| Special items | ---- | ---975K | ---- | ---- | ---- | ---- | ---- | -62.07%88K | ---- | -82.21%232K |
| Operating profit before the change of operating capital | ---- | 8.99%13.58M | ---- | -11.04%12.46M | ---- | 30.67%14.01M | ---- | -23.93%10.72M | ---- | -12.38%14.09M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -56.37%-4.12M | ---- | -742.17%-2.64M | ---- | 84.74%-313K | ---- | 70.60%-2.05M | ---- | -1,436.40%-6.98M |
| Accounts receivable (increase)decrease | ---- | -2,530.33%-13.44M | ---- | -132.32%-511K | ---- | 116.32%1.58M | ---- | -906.74%-9.69M | ---- | 1,401.25%1.2M |
| Accounts payable increase (decrease) | ---- | 461.05%4.69M | ---- | -51.58%-1.3M | ---- | 24.82%-857K | ---- | -127.74%-1.14M | ---- | 403.77%4.11M |
| prepayments (increase)decrease | ---- | -181.49%-678K | ---- | 454.04%832K | ---- | -328.16%-235K | ---- | 118.13%103K | ---- | -299.30%-568K |
| Special items for working capital changes | ---- | 587.01%1.88M | ---- | -98.45%-385K | ---- | 68.30%-194K | ---- | 71.91%-612K | ---- | -133.29%-2.18M |
| Cash from business operations | ---- | -77.47%1.91M | ---- | -39.50%8.46M | ---- | 624.40%13.99M | ---- | -127.56%-2.67M | ---- | -56.32%9.68M |
| Other taxs | ---- | 68.21%-555K | ---- | -30.98%-1.75M | ---- | -100.15%-1.33M | ---- | 81.85%-666K | ---- | -579.63%-3.67M |
| Special items of business | -887.96%-4.91M | ---- | 122.54%623K | ---- | -130.36%-2.76M | ---- | 319.56%9.11M | ---- | -487.39%-4.15M | ---- |
| Net cash from operations | -887.96%-4.91M | -79.87%1.35M | 122.54%623K | -46.93%6.72M | -130.36%-2.76M | 479.66%12.66M | 319.56%9.11M | -155.46%-3.33M | -487.39%-4.15M | -72.20%6.01M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -39.52%583K | 4.62%1.65M | 25.52%964K | 260.96%1.58M | --768K | 3,881.82%438K | ---- | -96.92%11K | -96.54%11K | -57.50%357K |
| Dividend received - investment | 44.44%13K | 5.56%19K | 0.00%9K | 20.00%18K | 28.57%9K | 50.00%15K | --7K | --10K | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | --50K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -16.67%-14K | 90.02%-180K | 98.79%-12K | -2,763.49%-1.8M | ---992K | 91.96%-63K | ---- | -102.06%-784K | -131.50%-757K | -78.80%-388K |
| Acquisition of subsidiaries | ---- | 1,047.50%2.27M | ---120K | 57.14%-240K | ---- | 28.21%-560K | ---- | ---780K | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | 104.41%15K | 85.93%-340K | 27.19%-340K | -4,639.22%-2.42M | ---467K | ---51K |
| Net cash from investment operations | -30.80%582K | 1,053.67%3.77M | 520.50%841K | 22.55%-395K | 39.94%-200K | 87.12%-510K | 72.55%-333K | -4,729.27%-3.96M | -13,377.78%-1.21M | -113.16%-82K |
| Net cash before financing | -395.56%-4.33M | -19.04%5.12M | 149.39%1.46M | -47.95%6.32M | -133.79%-2.96M | 266.55%12.15M | 263.66%8.77M | -223.00%-7.29M | -649.65%-5.36M | -73.35%5.93M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | -68.49%-123K | -96.23%-208K | -15.87%-73K | 30.26%-106K | 8.70%-63K | -8.57%-152K | -6.15%-69K | -28.44%-140K | -71.05%-65K | -60.29%-109K |
| Dividends paid - financing | 0.00%-2M | 37.50%-2M | 37.50%-2M | -33.33%-3.2M | -33.33%-3.2M | 33.33%-2.4M | 33.33%-2.4M | -2.86%-3.6M | -2.86%-3.6M | 0.00%-3.5M |
| Absorb investment income | ---- | ---- | ---- | --15K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 16.65%-2.97M | 34.34%-4.87M | 32.86%-3.57M | -15.96%-7.42M | -23.99%-5.31M | 15.60%-6.4M | 22.16%-4.29M | -19.31%-7.58M | -14.11%-5.51M | -14.42%-6.36M |
| Net Cash | -247.01%-7.3M | 122.52%247K | 74.58%-2.1M | -119.08%-1.1M | -284.53%-8.28M | 138.65%5.75M | 141.28%4.49M | -3,400.24%-14.88M | -96.14%-10.87M | -102.55%-425K |
| Begining period cash | 0.41%60.24M | -1.80%59.99M | -1.80%59.99M | 10.39%61.09M | 10.39%61.09M | -21.19%55.34M | -21.19%55.34M | -0.60%70.21M | -0.60%70.21M | 30.95%70.64M |
| Cash at the end | -8.55%52.93M | 0.41%60.24M | 9.61%57.88M | -1.80%59.99M | -11.73%52.81M | 10.39%61.09M | 0.80%59.82M | -21.19%55.34M | -8.83%59.35M | -0.60%70.21M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.